Live Webinar
GXC 2025 Online Virtual Conference - Mental Health Without Borders
Psychedelic Medicine in Action: Rationale and Results of Recent Trials
|
Psychedelic Medicine in Action: Rationale and Results of Recent Trials
1.0 CE Hours
Intermediate
$75 - $150
Pricing
References
References
- Carhart-Harris, R.L., et al. (2024). Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study (Protocol). Frontiers in Psychiatry, 12, Article 735523. https://doi.org/10.3389/fpsyt.2021.735523 ICHGCP+8The Australian+8ScienceBlog.com+8Frontiers+4ICHGCP+4Carhart-Harris Lab+4Frontiers+6Frontiers+6SpringerLink+6
- Bornemann, J., Carhart-Harris, R.L., et al. (2024). Psilocybin in Patients with Fibromyalgia: Brain Biomarkers of Action (Protocol). Frontiers in Psychiatry, Article 1320780. https://doi.org/10.3389/fpsyt.2024.1320780 ICHGCP+10spiral.imperial.ac.uk+10Frontiers+10
- Carhart-Harris, R.L., Giribaldi, B., Watts, R., Baker-Jones, M., Murphy-Beiner, A., Murphy, R., Martell, J., Blemings, A., Erritzoe, D., & Nutt, D.J. (2021). Trial of psilocybin versus escitalopram for depression. New England Journal of Medicine, 384, 1402-1411. https://doi.org/10.1056/NEJMoa2032994 ICHGCP+1